Identification of recurrent SMO and BRAF mutations in ameloblastomas.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMC 4418232)

Published in Nat Genet on May 25, 2014

Authors

Robert T Sweeney1, Andrew C McClary1, Benjamin R Myers2, Jewison Biscocho1, Lila Neahring3, Kevin A Kwei4, Kunbin Qu5, Xue Gong6, Tony Ng7, Carol D Jones6, Sushama Varma6, Justin I Odegaard6, Toshihiro Sugiyama8, Souichi Koyota8, Brian P Rubin9, Megan L Troxell10, Robert J Pelham5, James L Zehnder6, Philip A Beachy3, Jonathan R Pollack6, Robert B West6

Author Affiliations

1: 1] Department of Pathology, Stanford University, Stanford, California, USA. [2].
2: 1] Department of Biochemistry, Stanford University, Stanford, California, USA. [2] Department of Developmental Biology, Stanford University, Stanford, California, USA. [3] Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA. [4] Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA. [5].
3: 1] Department of Biochemistry, Stanford University, Stanford, California, USA. [2] Department of Developmental Biology, Stanford University, Stanford, California, USA. [3] Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA. [4] Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA.
4: 1] Genomic Health, Redwood City, California, USA. [2].
5: Genomic Health, Redwood City, California, USA.
6: Department of Pathology, Stanford University, Stanford, California, USA.
7: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
8: Department of Biochemistry, Akita University Graduate School of Medicine, Akita, Japan.
9: Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
10: Department of Pathology, Oregon Health and Sciences University, Portland, Oregon, USA.

Articles citing this

Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat Genet (2016) 1.05

Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol (2015) 1.00

Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries. Biomark Cancer (2015) 0.93

Hedgehog signaling inhibitors as anti-cancer agents in osteosarcoma. Cancers (Basel) (2015) 0.83

ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol (2015) 0.83

Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. J Invest Dermatol (2015) 0.82

Smoothened goes molecular: new pieces in the hedgehog signaling puzzle. J Biol Chem (2014) 0.82

Novel targets for the treatment of ameloblastoma. J Dent Res (2014) 0.80

Cancer genomics: why rare is valuable. J Mol Med (Berl) (2015) 0.80

Molecular and genetic aspects of odontogenic lesions. Head Neck Pathol (2014) 0.79

A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome. Am J Hum Genet (2016) 0.77

Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma. PLoS One (2017) 0.75

Ameloblastoma Phenotypes Reflected in Distinct Transcriptome Profiles. Sci Rep (2016) 0.75

Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature. Oncotarget (2016) 0.75

Multi-recurrent invasive ameloblastoma: A surgical challenge. Int J Surg Case Rep (2016) 0.75

Smoothened gene alterations in keratocystic odontogenic tumors. Head Face Med (2014) 0.75

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol (2017) 0.75

Primordial odontogenic tumor: An immunohistochemical profile. Med Oral Patol Oral Cir Bucal (2017) 0.75

Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis. Curr Oral Health Rep (2016) 0.75

FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol (2017) 0.75

The regulation of bone turnover in ameloblastoma using an organotypic in vitro co-culture model. J Tissue Eng (2016) 0.75

Genetic basis of calcifying cystic odontogenic tumors. PLoS One (2017) 0.75

Articles cited by this

Fast gapped-read alignment with Bowtie 2. Nat Methods (2012) 83.79

Mutations of the BRAF gene in human cancer. Nature (2002) 65.42

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51

Primer3--new capabilities and interfaces. Nucleic Acids Res (2012) 20.34

Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature (2000) 10.04

Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature (1998) 7.43

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol (2011) 6.23

Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032. J Transl Med (2010) 5.57

Sonic hedgehog regulates growth and morphogenesis of the tooth. Development (2000) 4.71

deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol (2011) 4.66

SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics (2010) 4.02

Essential role for Sonic hedgehog during hair follicle morphogenesis. Dev Biol (1999) 3.62

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science (2013) 3.45

Structure of the human smoothened receptor bound to an antitumour agent. Nature (2013) 3.08

The cutting-edge of mammalian development; how the embryo makes teeth. Nat Rev Genet (2004) 2.89

ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics (2011) 2.74

Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell (2013) 2.62

The hair follicle as a dynamic miniorgan. Curr Biol (2009) 2.52

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. Cancer Res (2011) 2.22

Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc Natl Acad Sci U S A (2010) 2.00

High frequency of BRAF V600E mutations in ameloblastoma. J Pathol (2014) 1.79

A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res (2011) 1.77

Odontogenic tumors. Classification, histopathology, and clinical behavior in man and domesticated animals. Cancer (1961) 1.64

Selective depletion of rRNA enables whole transcriptome profiling of archival fixed tissue. PLoS One (2012) 1.62

CRAVAT: cancer-related analysis of variants toolkit. Bioinformatics (2013) 1.43

Activation of FGF receptors by mutations in the transmembrane domain. Oncogene (1997) 1.38

Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res (2002) 1.19

Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response. Dev Cell (2013) 1.15

Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail. Brain Pathol (2013) 1.09

The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol (2010) 1.06

Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas. J Oral Pathol Med (2004) 0.98

Establishment and characterization of a spontaneously immortalized mouse ameloblast-lineage cell line. Biochem Biophys Res Commun (2003) 0.97

Establishment of ameloblastoma cell line, AM-1. J Oral Pathol Med (1998) 0.94

Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations. Am J Surg Pathol (2013) 0.85